OXCARBAZEPINE AS AN ADJUNCT OF ANTIPSYCHOTIC THERAPY IN ACUTE SCHIZOPHRENIA: A DOUBLE-BLIND, RANDOMISED PLACEBO-CONTROLLED CLINICAL TRIAL

被引：0
|
作者：
Koethe, D. [1 ]
Kranaster, L. [1 ]
Hellmich, M. [1 ]
Nolden, B. M. [1 ]
Klosterkoetter, J. [1 ]
机构：
[1] Univ Cologne, D-50931 Cologne, Germany
来源：
EUROPEAN PSYCHIATRY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P03-156
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Shiina, Akihiro
    Shirayama, Yukihiko
    Niitsu, Tomihisa
    Hashimoto, Tasuku
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Haraguchi, Tadashi
    Kanahara, Nobuhisa
    Shiraishi, Tetsuya
    Fujisaki, Mihisa
    Fukami, Goro
    Nakazato, Michiko
    Iyo, Masaomi
    Hashimoto, Kenji
    ANNALS OF GENERAL PSYCHIATRY, 2010, 9
  • [2] Simvastatin adjunct therapy for negative symptoms of schizophrenia: a randomized double-blind placebo-controlled trial
    Tajik-Esmaeeli, Soode
    Moazen-Zadeh, Ehsan
    Abbasi, Niloofar
    Shariat, Seyed V.
    Rezaei, Farzin
    Salehi, Bahman
    Akhondzadeh, Shahin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (02) : 87 - 94
  • [3] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Akihiro Shiina
    Yukihiko Shirayama
    Tomihisa Niitsu
    Tasuku Hashimoto
    Taisuke Yoshida
    Tadashi Hasegawa
    Tadashi Haraguchi
    Nobuhisa Kanahara
    Tetsuya Shiraishi
    Mihisa Fujisaki
    Goro Fukami
    Michiko Nakazato
    Masaomi Iyo
    Kenji Hashimoto
    Annals of General Psychiatry, 9
  • [4] Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
    Barnes, Thomas R. E.
    Leeson, Verity C.
    Paton, Carol
    Costelloe, Ceire
    Simon, Judit
    Kiss, Noemi
    Osborn, David
    Killaspy, Helen
    Craig, Tom K. J.
    Lewis, Shon
    Keown, Patrick
    Ismail, Shajahan
    Crawford, Mike
    Baldwin, David
    Lewis, Glyn
    Geddes, John
    Kumar, Manoj
    Pathak, Rudresh
    Taylor, Simon
    HEALTH TECHNOLOGY ASSESSMENT, 2016, 20 (29) : 1 - +
  • [5] Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
    Afshar, H.
    Roohafza, H.
    Mousavi, G.
    Golchin, S.
    Toghianifar, N.
    Sadeghi, M.
    Talaei, M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (02) : 157 - 162
  • [6] Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
    Nakamura, Mitsutaka
    Ogasa, Masaaki
    Guarino, John
    Phillips, Debra
    Severs, Joseph
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (06) : 829 - 836
  • [7] Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Kashani, Ladan
    Shams, Nazila
    Moazen-Zadeh, Ehsan
    Karkhaneh-Yousefi, Mohammad-Ali
    Sadighi, Gita
    Khodaie-Ardakani, Mohammad-Reza
    Rezaei, Farzin
    Rahiminejad, Fatemeh
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 70 - 77
  • [8] "Extended" Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia: A Double-Blind, Placebo-Controlled Trial
    Remington, Gary
    Seeman, Philip
    Feingold, Alan
    Mann, Steve
    Shammi, Chekkera
    Kapur, Shitij
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (08) : 1042 - 1048
  • [9] Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial
    Mozen-Zadeh, Ehsan
    Bayanati, Samaneh
    Ziafat, Kimia
    Rezaei, Farzin
    Mesgarpour, Bita
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (05) : 506 - 513
  • [10] Oxcarbazepine in patients with impulsive aggression - A double-blind, placebo-controlled trial
    Mattes, JA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (06) : 575 - 579
12345